What’s Happening With PFE Stock? - Paperblog

Pfizer stock (NYSE: PFE) is down 7% in a month, amid rising concerns over the future of vaccines under Robert F. Kennedy Jr. in the new government, given the perception of him being a …

7%
OFF

What’s Happening With PFE Stock? - Paperblog

2 weeks from now

Pfizer stock (NYSE: PFE) is down 7% in a month, amid rising concerns over the future of vaccines under Robert F. Kennedy Jr. in the new government, given the perception of him being a …

paperblog.com

5%
OFF

What To Expect From PFE Stock In 2025? - Forbes

2 weeks from now

12 hours ago · Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other …

forbes.com

5%
OFF

What's Next For Pfizer Stock? - Nasdaq

2 weeks from now

Dec 19, 2024 · Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in …

nasdaq.com

50%
OFF

Pfizer Stock Is Moving Higher Monday: What's Driving The Action?

2 weeks from now

Oct 7, 2024 · Pfizer shares are down more than 50% since the stock hit an all-time high around $61 in December 2021 after the company was the first to deliver a COVID-19 vaccine.

benzinga.com

15%
OFF

What’s In Store For PFE Stock In 2025? - Trefis.com

2 weeks from now

1 day ago · What’s In Store For PFE Stock In 2025? January 15th, 2025 by Trefis Team + 37.15% Upside 26.41 Market 36.22 Trefis PFE ... What’s Happening With LLY Stock. CL Stock vs. …

trefis.com

15%
OFF

Should You Pick Pfizer Stock At $30? - Forbes

2 weeks from now

Nov 3, 2023 · PFE stock has seen a decline of 15% from levels of $35 in early January 2021 to around $30 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period.

forbes.com

5%
OFF

What To Expect From PFE Stock In 2025? - Public.com

2 weeks from now

1 day ago · Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other …

public.com

FAQs about What’s Happening With PFE Stock? - Paperblog Coupon?

What happened to PFE stock?

PFE stock declined from nearly $12 in September 2007 (pre-crisis peak) to $7 in March 2009 (as the markets bottomed out), implying it lost 45% of its pre-crisis value. It recovered post the 2008 crisis to levels of around $10 in early 2010, rising about 52% between March 2009 and January 2010. ...

Is PFE stock more volatile than the S&P 500?

The decrease in PFE stock over the last few years has been far from consistent, with annual returns being considerably more volatile than the S&P 500. Returns for PFE stock were 67% in 2021, -10% in 2022, and -41% in 2023. In contrast, the Trefis High Quality Portfolio, with a collection of 30 stocks, is considerably less volatile. ...

What happened to Pfizer (PFE)?

In the latest trading session, Pfizer (PFE) closed at $26.41, marking a -1.46% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.12%. At the same time, the Dow added 0.52%, and the tech-heavy Nasdaq lost 0.23%. ...

How volatile is PFE stock?

Looking at a slightly longer term, the performance of PFE stock with respect to the index over the last four-year period has been quite volatile. Returns for the stock were 67% in 2021, -10% in 2022, -41% in 2023, and -2% in 2024. The Trefis High Quality Portfolio, with a collection of 30 stocks, is considerably less volatile. ...

Is PFE a good stock to buy?

Both of these developments are positive for the stock. But, looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent years. In contrast, the Trefis High Quality Portfolio, with a collection of 30 stocks, is considerably less volatile. ...

Should you buy Pfizer (PFE)?

Here's why these two high-yield dividend stocks deserve a closer look from income and value investors with a long-term outlook. Pfizer (NYSE: PFE) ranks among healthcare's most reliable dividend payers, but recent struggles have pushed its stock down 13.8% this year. ...